Carlos Slim Center for Health Research
Founded in 2010 by the Carlos Slim Foundation, the Carlos Slim Center for Health Research at the Broad Institute seeks to ensure that the genomic revolution in biomedicine benefits people throughout the Americas and the world.
The partnership brings together the Broad Institute, the Carlos Slim Health Institute, and other research institutions in Mexico, the United States, and several other countries with a shared commitment to transform human health. The center’s scientists are conducting groundbreaking research to uncover the biological mechanisms behind common diseases — such as type 2 diabetes and cancer — that impact populations in Mexico and Latin America. These insights will point the way to new and more effective therapeutics. The center also aims to accelerate the development of genomics research in Mexico by training scientists and enhancing research capacity.
Klarman Cell Observatory
Understanding how human cells function in health and disease and developing effective treatments requires a comprehensive picture of cellular components and circuits. Until recently, research on cell circuits was limited to single-cell organisms, which are significantly less complex than human cells. In 2012, the Klarman Family Foundation established the Klarman Cell Observatory as a pilot effort to decipher the inner workings of human cells and to foster new insights into the biological underpinnings of disease.
To propel our understanding of cell circuitry, the Observatory brings together scientists from a range of disciplines and works closely with other researchers at the Broad. It is also developing innovative experimental and computational methods to advance this emerging field. The Observatory also oversees close collaborations with scientists from Israel in order to help advance the country’s biomedical research, including an annual symposium, fellowships and other training opportunities, and joint projects.
Stanley Center for Psychiatric Research
Serious psychiatric disorders are the leading cause of disability worldwide. However, research on these devastating diseases has long been stalled because knowledge of their biological underpinnings remained elusive. Founded in 2007, the mission of the Stanley Center for Psychiatric Research is to decrease the burden of psychiatric illnesses by bringing the insights of modern genomics to bear on neurobiology and therapeutics.
The Stanley Center has extensive collaborations with investigators both within the Harvard, MIT, and Harvard-affiliated hospital communities and across the world. To date, Stanley Center researchers and their collaborators have assembled the world’s largest collection of DNA samples of psychiatric research. They are also working to uncover the genetic underpinnings of schizophrenia, bipolar disorder, autism, and ADHD, while at the same time, developing tools and methods to analyze research findings. By uncovering the biology of psychiatric disease, the Stanley Center hopes to find the way to new therapies.